ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.

$4.52  -0.18 (-3.83%)
As of 06/29/2022 14:41:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  12/08/2020
Outstanding shares:  692,072,184
Average volume:  1,334,561
Market cap:   $3,238,897,821
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMW4NZ9
Valuation   (See tab for details)
PE ratio:   -5.66
PB ratio:   1.74
PS ratio:   62.51
Return on equity:   -38.17%
Net income %:   -1,655.53%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy